Vitas Laboratory LLC

Vitas Laboratory LLC was paid $569K by Medicaid between Jan 2018 and Sep 2019, across 41 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 32% of everything it billed.

33Billing provider infoVITAS LABORATORY LLC
BARLING, AR 72923

33aNPI1528507290assigned 02/14/2017

33bProvider typeClinical Medical Laboratory

28Total paid$569K

24GClaims43,342

24DCodes billed41

24AFirst – last monthJan 2018 – Sep 2019

Compared with peers

Next to other Clinical Medical Laboratory providers in Arkansas

Rank by total paid#7 of 24

Median peer was paid$53K

This provider vs. median11×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	18,065	$344K
2019	25,277	$225K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	32%	6,163	3,913	$185K
80323		8.8%	2,638	1,620	$50K
80358		7.3%	5,210	1,624	$41K
80356		7.1%	2,645	1,624	$40K
80348		5.6%	2,643	1,622	$32K
80354		5.3%	2,643	1,623	$30K
80364		5.1%	2,649	1,624	$29K
80372		5.0%	2,641	1,623	$29K
80324		4.5%	2,640	1,622	$26K
80353		4.3%	2,647	1,625	$25K
80359		3.7%	2,643	1,624	$21K
80360		3.7%	2,637	1,619	$21K

29 more codes

80355		3.6%	2,647	$20K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	1,969	$3K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	18	$2K
87503		<1%	18	$1K
87634		<1%	18	$1K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	18	$1K
82670		<1%	48	$893.86
84403		<1%	49	$850.50
87254		<1%	18	$714.96
80050	General health panel	<1%	42	$713.00
84270		<1%	47	$675.18
87581		<1%	18	$641.52
87486		<1%	18	$641.52
84146		<1%	49	$638.40
83001		<1%	50	$629.64
83002		<1%	50	$627.48
82378		<1%	41	$624.75
84481		<1%	52	$605.72
80061	Lipid panel	<1%	53	$466.57
87797		<1%	18	$444.60
83036	Hemoglobin; glycosylated (A1C)	<1%	56	$387.56
87809		<1%	18	$322.20
84439		<1%	50	$305.64
86038		<1%	34	$295.88
81001		<1%	78	$260.36
87279		<1%	18	$243.18
87299		<1%	18	$238.32
87807		<1%	18	$219.06
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	12	$195.02

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDOOLEY, CHRISTOPHER (OWNER/ CHIEF OF OPERATION)